| T | Act | Project | Year | Sub | Principal Investigator(s)/ Project Leader(s) | Organization | Fiscal Year | Admin IC | Funding IC | FY Total Cost by IC | Similar Projects |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors | |||||||||||
| 5Tf | R01Actf | CA281862Projectf | 02Yearf | ROSWELL PARK CANCER INSTITUTE CORP | 2024 | NCI | NCI | $735,428 | View View Similar Projects Similar Projectsf | ||
| A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors | |||||||||||
| 1Tf | R01Actf | CA281862Projectf | 01Yearf | ROSWELL PARK CANCER INSTITUTE CORP | 2023 | NCI | NCI | $815,928 | View View Similar Projects Similar Projectsf | ||
| T | Act | Project | Year | Sub | Principal Investigator(s)/ Project Leader(s) | Organization | Fiscal Year | Admin IC | Funding IC | FY Total Cost by IC | Similar Projects |
|---|